Presentations

Date	Title
Sep 26, 2024	Sol-Gel Corporate Presentation 5.1 MB
Nov 09, 2023	Sol-Gel Corporate Presentation 1.9 MB
Jan 27, 2023	Patidegib Acquisition Call 1.6 MB
Nov 10, 2022	Sol-Gel Corporate Presentation 2.3 MB
Apr 18, 2022	Papulopustular Rosacea: Where are we Now & What is New 3.6 MB
Jan 21, 2020	Efficacy and Safety of Microencapsulated Benzoyl Peroxide (E-BPO) Cream, 5% in Papulopustular Rosacea: Results from Two Phase 3, Vehicle-Controlled Trials 1.4 MB
Jan 21, 2020	Twyneo® (Microencapsulated Benzoyl Peroxide 3%, Tretinoin 0.1%) Phase 3 Efficacy and Safety: Results from Two Randomized Controlled Clinical Trials 842.4 KB
Jan 21, 2020	Characterization of Microencapsulated Benzoyl Peroxide (E-BPO) for the Treatment of Papulopustular Rosacea 1.5 MB
Jan 08, 2020	Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne 768.1 KB
Jul 25, 2019	Sol-Gel Technologies Analyst and Investor Day Presentation 2.9 MB

Subscribe to our email alerts